ArticleFrontiers in endocrinology2025
MRI-based SIR quantitative biomarkers: a novel imaging diagnostic strategy for thyroid eye disease activity staging.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Orbital MRI for thyroid eye disease activity staging: a systematic review and meta-analysis.BMC ophthalmology · 2026Pooled it
- Article
- A Pilot MRI Study of Upward Gaze-Induced Intraocular Pressure Elevation in Thyroid Eye Disease.Diagnostics (Basel, Switzerland) · 2026Article
- Teprotumumab N01 for thyroid eye disease in China: clinical outcomes and quantitative MRI correlations.Frontiers in medicine · 2026Article
- Multimodal MRI radiomics-clinical fusion model predicts intravenous glucocorticoid response in thyroid eye disease.Frontiers in endocrinology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate the diagnostic efficacy of magnetic resonance imaging (MRI)-based signal intensity ratio (SIR) between extraocular muscles and white matter/temporal muscle for staging thyroid eye disease (TED) activity, and to provide a novel approach for diagnosis in active TED patients. Methods: A number of 40 patients with TED (79 eyes) and 65 controls (65 eyes) were recruited. MRI-based parameters of four extraocular muscles, ipsilateral white matter, temporal muscle, and other clinical factors were retrospectively collected. Patients were grouped according to disease activity determined by the Clinical Activity Score (CAS), and intergroup analysis was subsequently performed based on this classification. The signal intensities were measured using fat-suppressed T2-weighted imaging (T2WI-FS) sequences from MRI. The SIR of the extraocular rectus muscle to that of the ipsilateral white matter represents SIR1, while the SIR of the extraocular rectus muscle to that of the ipsilateral temporalis muscle represents SIR2. Results: Active TED group demonstrated elevated SIR1 and SIR2 values across all rectus muscles compared to control group and inactive TED group (P<0.05), with no differences between inactive TED and controls. Receiver operator characteristic (ROC) curve analysis identified SIR2 as superior to SIR1 for most muscles, with inferior rectus SIR1 achieving the highest AUC (0.837). Based on 95% confidence intervals and cutoff values, we propose redefining TED staging: control ranges (0.936-1.019) as absolute inactive phase, active TED ranges (1.210-1.344) as absolute active phase, and transitional values (1.019-1.210) as clinical vigilance phase requiring heightened attention. The model suggests that patients currently defined as "inactive" by CAS may have subclinical inflammation, explaining paradoxical disease progression in some cases. Conclusions: The signal intensity ratio (SIR) from fat-suppressed T2-weighted (T2WI-FS) sequences serves as a reliable predictor for TED activity. The 95% confidence interval (CI) for SIR values can provide a new strategy for early diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.